- Home
- BSM vs BHC Comparison
BSM vs BHC Comparison
Compare BSM & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSM | BHC |
|---|---|---|
| Founded | 1876 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.5B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | BSM | BHC |
|---|---|---|
| Price | $14.99 | $5.88 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $13.00 | $8.67 |
| AVG Volume (30 Days) | 344.4K | ★ 2.2M |
| Earning Date | 02-23-2026 | 02-18-2026 |
| Dividend Yield | ★ 8.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.16 | 0.97 |
| Revenue | $412,814,000.00 | ★ $10,029,000,000.00 |
| Revenue This Year | $1.58 | $6.81 |
| Revenue Next Year | $8.38 | $4.11 |
| P/E Ratio | $12.96 | ★ $6.08 |
| Revenue Growth | N/A | ★ 5.86 |
| 52 Week Low | $11.78 | $4.25 |
| 52 Week High | $15.52 | $8.69 |
Technical Indicators
Market Signals| Indicator | BSM | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 62.11 | 34.44 |
| Support Level | $14.65 | $5.62 |
| Resistance Level | $14.99 | $5.85 |
| Average True Range (ATR) | 0.28 | 0.20 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 71.27 | 19.35 |
Price Performance
Historical ComparisonAbout BSM Black Stone Minerals L.P.
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.